The rate hypothesis and agonist substitution approaches to cocaine abuse treatment.
Gorelick
D A
DA
Treatment Branch, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, USA.
D000818:Animals; D016642:Bupropion / Q000627:therapeutic use; D003042:Cocaine / Q000008:administration & dosage / Q000493:pharmacokinetics; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use; D006801:Humans; D008454:Mazindol / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology
D018765:Dopamine Uptake Inhibitors; D010879:Piperazines; D016642:Bupropion; C043425:vanoxerine; D008454:Mazindol; D003042:Cocaine